Atlas Trials

First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor

Clinical trial NCT02661373 · COMPLETED

Trial details

NCT number
NCT02661373
Sponsor
St. Jude Children's Research Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2016-03-01
Primary completion
2018-03-09
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.